Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1971 Jan;50(1):131–141. doi: 10.1172/JCI106467

Cyclic 3′,5′-adenosine monophosphate in human blood platelets

II. Effect of N6-2′-0-dibutyryl cyclic 3′,5′-adenosine monophosphate on platelet function

Edwin W Salzman 1,2, Linda Levine 1,2
PMCID: PMC291901  PMID: 4322665

Abstract

The relation of cyclic 3′,5′-adenosine monophosphate to platelet function has been studied by investigating the influence of this compound and of its N6-2′-0-dibutyryl derivative on platelet aggregation and other aspects of platelet behavior after demonstration of adenyl cyclase activity in disrupted platelets.

Dibutyryl cyclic AMP inhibited platelet aggregation induced by ADP, epinephrine, collagen, and thrombin. Cyclic AMP was also inhibitory but was less effective. The platelet “release reaction” was also inhibited; specifically, there was inhibition of the induction of platelet factor 3 activity and of the release of labeled 5-hydroxytryptamine. Platelet swelling produced by ADP was not inhibited.

The action of dibutyryl cyclic AMP did not result from contamination with 5′-AMP, nor was it attributable to production of 5′-AMP by plasma enzymes. Dibutyryl cyclic AMP was degraded to 2′-O-monobutyryl cyclic AMP and to cyclic AMP in plasma, but plasma exhibited no cyclic nucleotide phosphodiesterase activity, and the production of 5′-AMP did not occur. The in vitro effects of dibutyryl cyclic AMP were associated with uptake of the compound by platelets.

Adenyl cyclase activity of platelet homogenates was demonstrated with production of 9.27 × 10-11 (±2.62 × 10-11) mole cyclic AMP per min per 1010 platelets. The activity was increased by NaF and by prostaglandin PGE1 and was decreased by epinephrine. The effect of epinephrine was blocked by phentolamine but not by propanolol. Adenyl cyclase activity was also inhibited by collagen, 5-hydroxytryptamine, and thrombin. ADP, dibutyryl cyclic AMP, and cyclic AMP did not alter adenyl cyclase activity.

These observations are consistent with the hypothesis that platelet aggregation is favored by a decrease in platelet cyclic AMP and inhibited by an increase in cyclic AMP.

Full text

PDF
131

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASTER R. H., JANDL J. H. PLATELET SEQUESTRATION IN MAN. I. METHODS. J Clin Invest. 1964 May;43:843–855. doi: 10.1172/JCI104970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Abdulla Y. H. Beta-adrenergic receptors in human platelets. J Atheroscler Res. 1969 Mar-Apr;9(2):171–177. doi: 10.1016/s0368-1319(69)80052-9. [DOI] [PubMed] [Google Scholar]
  3. Ardlie N. G., Glew G., Schultz B. G., Schwartz C. J. Inhibition and reversal of platelet aggregation by methyl xanthines. Thromb Diath Haemorrh. 1967 Dec 31;18(3-4):670–673. [PubMed] [Google Scholar]
  4. BORN G. V. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 1962 Jun 9;194:927–929. doi: 10.1038/194927b0. [DOI] [PubMed] [Google Scholar]
  5. BORN G. V., CROSS M. J. THE AGGREGATION OF BLOOD PLATELETS. J Physiol. 1963 Aug;168:178–195. doi: 10.1113/jphysiol.1963.sp007185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. BRECHER G., CRONKITE E. P. Morphology and enumeration of human blood platelets. J Appl Physiol. 1950 Dec;3(6):365–377. doi: 10.1152/jappl.1950.3.6.365. [DOI] [PubMed] [Google Scholar]
  7. Breckenridge B. M. Cyclic AMP and drug action. Annu Rev Pharmacol. 1970;10:19–34. doi: 10.1146/annurev.pa.10.040170.000315. [DOI] [PubMed] [Google Scholar]
  8. Bull B. S., Zucker M. B. Changes in platelet volume produced by temperature, metabolic inhibitors, and aggregating agents. Proc Soc Exp Biol Med. 1965 Nov;120(2):296–301. doi: 10.3181/00379727-120-30516. [DOI] [PubMed] [Google Scholar]
  9. Butcher R. W., Robison G. A., Hardman J. G., Sutherland E. W. The role of cyclic AMP in hormone actions. Adv Enzyme Regul. 1968;6:357–389. doi: 10.1016/0065-2571(68)90023-x. [DOI] [PubMed] [Google Scholar]
  10. Butcher R. W. Rose of cyclic AMP in hormone actions. N Engl J Med. 1968 Dec 19;279(25):1378–1384. doi: 10.1056/NEJM196812192792507. [DOI] [PubMed] [Google Scholar]
  11. Bär H. P., Hechter O. Adenyl cyclase assay in fat cell ghosts. Anal Biochem. 1969 Jun;29(3):476–489. doi: 10.1016/0003-2697(69)90332-7. [DOI] [PubMed] [Google Scholar]
  12. CLAYTON S., BORN G. V., CROSS M. J. INHIBITION OF THE AGGREGATION OF BLOOD PLATELETS BY NUCLEOSIDES. Nature. 1963 Oct 12;200:138–139. doi: 10.1038/200138a0. [DOI] [PubMed] [Google Scholar]
  13. Castaldi P. A., Larrieu M. J., Caen J. Availability of platelet Factor 3 and activation of factor XII in thrombasthenia. Nature. 1965 Jul 24;207(995):422–424. doi: 10.1038/207422a0. [DOI] [PubMed] [Google Scholar]
  14. GAARDER A., JONSEN J., LALAND S., HELLEM A., OWREN P. A. Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets. Nature. 1961 Nov 11;192:531–532. doi: 10.1038/192531a0. [DOI] [PubMed] [Google Scholar]
  15. GRETTE K. Studies on the mechanism of thrombin-catalyzed hemostatic reactions in blood platelets. Acta Physiol Scand Suppl. 1962;195:1–93. [PubMed] [Google Scholar]
  16. HARDISTY R. M., DORMANDY K. M., HUTTON R. A. THROMBASTHENIA. STUDIES ON THREE CASES. Br J Haematol. 1964 Jul;10:371–387. doi: 10.1111/j.1365-2141.1964.tb00714.x. [DOI] [PubMed] [Google Scholar]
  17. HARDISTY R. M., HUTTON R. A. THE KAOLIN CLOTTING TIME OF PLATELET-RICH PLASMA: A TEST OF PLATELET FACTOR-3 AVAILABILITY. Br J Haematol. 1965 May;11:258–268. doi: 10.1111/j.1365-2141.1965.tb06586.x. [DOI] [PubMed] [Google Scholar]
  18. Henion W. F., Sutherland E. W., Posternak T. Effects of derivatives of adenosine 3',5'-phosphate on liver slices and intact animals. Biochim Biophys Acta. 1967 Oct 9;148(1):106–113. doi: 10.1016/0304-4165(67)90284-x. [DOI] [PubMed] [Google Scholar]
  19. MITCHELL J. R., SHARP A. A. PLATELET CLUMPING IN VITRO. Br J Haematol. 1964 Jan;10:78–93. doi: 10.1111/j.1365-2141.1964.tb00681.x. [DOI] [PubMed] [Google Scholar]
  20. Macmillan D. C. Secondary clumping effect in human citrated platelet-rich plasma produced by adenosine diphosphate and adrenaline. Nature. 1966 Jul 9;211(5045):140–144. doi: 10.1038/211140a0. [DOI] [PubMed] [Google Scholar]
  21. Marquis N. R., Becker J. A., Vigdahl R. L. Platelet aggregation. 3. An epinephrine induced decrease in cyclic AMP synthesis. Biochem Biophys Res Commun. 1970 Jun 5;39(5):783–789. doi: 10.1016/0006-291x(70)90391-8. [DOI] [PubMed] [Google Scholar]
  22. Marquis N. R., Vigdahl R. L., Tavormina P. A. Platelet aggregation. I. Regulation by cyclic AMP and prostaglandin E1. Biochem Biophys Res Commun. 1969 Sep 10;36(6):965–972. doi: 10.1016/0006-291x(69)90298-8. [DOI] [PubMed] [Google Scholar]
  23. Michal F., Firkin B. G. Physiological and pharmacological aspects of the platelet. Annu Rev Pharmacol. 1969;9:95–118. doi: 10.1146/annurev.pa.09.040169.000523. [DOI] [PubMed] [Google Scholar]
  24. Mills D. C., Robb I. A., Roberts G. C. The release of nucleotides, 5-hydroxytryptamine and enzymes from human blood platelets during aggregation. J Physiol. 1968 Apr;195(3):715–729. doi: 10.1113/jphysiol.1968.sp008484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. O'BRIEN J. R. A COMPARISON OF PLATELET AGGREGATION PRODUCED BY SEVEN COMPOUNDS AND A COMPARISON OF THEIR INHIBITORS. J Clin Pathol. 1964 May;17:275–281. doi: 10.1136/jcp.17.3.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. O'BRIEN J. R. SOME EFFECTS OF ADRENALINE AND ANTI-ADRENALINE COMPOUNDS ON PLATELETS IN VITRO AND IN VIVO. Nature. 1963 Nov 23;200:763–764. doi: 10.1038/200763a0. [DOI] [PubMed] [Google Scholar]
  27. POSTERNAK T., SUTHERLAND E. W., HENION W. F. Derivatives of cyclic 3',5'-adenosine monophosphate. Biochim Biophys Acta. 1962 Dec 17;65:558–560. doi: 10.1016/0006-3002(62)90475-4. [DOI] [PubMed] [Google Scholar]
  28. PROCTOR R. R., RAPAPORT S. I. The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies. Am J Clin Pathol. 1961 Sep;36:212–219. doi: 10.1093/ajcp/36.3.212. [DOI] [PubMed] [Google Scholar]
  29. Packham M. A., Warrior E. S., Glynn M. F., Senyi A. S., Mustard J. F. Alteration of the response of platelets to surface stimuli by pyrazole compounds. J Exp Med. 1967 Jul 1;126(1):171–188. doi: 10.1084/jem.126.1.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Robison G. A., Butcher R. W., Sutherland E. W. Adenyl cyclase as an adrenergic receptor. Ann N Y Acad Sci. 1967 Feb 10;139(3):703–723. doi: 10.1111/j.1749-6632.1967.tb41239.x. [DOI] [PubMed] [Google Scholar]
  31. Robison G. A., Butcher R. W., Sutherland E. W. Cyclic AMP. Annu Rev Biochem. 1968;37:149–174. doi: 10.1146/annurev.bi.37.070168.001053. [DOI] [PubMed] [Google Scholar]
  32. Rossi E. C. The effect of imidazole upon platelets incubated in vitro. Thromb Diath Haemorrh. 1968 Mar 31;19(1):53–63. [PubMed] [Google Scholar]
  33. Rysánek K., Svehla C., Spánková H., Mlejnková M. Comparison of the effect of various sypathicolytics on thrombocyte aggregation. J Pharm Pharmacol. 1968 Feb;20(2):154–155. doi: 10.1111/j.2042-7158.1968.tb09709.x. [DOI] [PubMed] [Google Scholar]
  34. SPAET T. H., ZUCKER M. B. MECHANISM OF PLATELET PLUG FORMATION AND ROLE OF ADENOSINE DIPHOSPHATE. Am J Physiol. 1964 Jun;206:1267–1274. doi: 10.1152/ajplegacy.1964.206.6.1267. [DOI] [PubMed] [Google Scholar]
  35. SUTHERLAND E. W., RALL T. W., MENON T. Adenyl cylase. I. Distribution, preparation, and properties. J Biol Chem. 1962 Apr;237:1220–1227. [PubMed] [Google Scholar]
  36. Salzman E. W., Ashford T. P., Chambers D. A., Neri L. L. Platelet incorporation of labelled adenosine and adenosine diphosphate. Thromb Diath Haemorrh. 1969 Nov 15;22(2):304–315. [PubMed] [Google Scholar]
  37. Salzman E. W., Neri L. L. Cyclic 3',5'-adenosine monophosphate in human blood platelets. Nature. 1969 Nov 8;224(5219):609–610. doi: 10.1038/224609a0. [DOI] [PubMed] [Google Scholar]
  38. Streeto J. M., Reddy W. J. An assay for adenyl cyclase. Anal Biochem. 1967 Dec;21(3):416–426. doi: 10.1016/0003-2697(67)90316-8. [DOI] [PubMed] [Google Scholar]
  39. Weiss H. J., Aledort L. M., Kochwa S. The effect of salicylates on the hemostatic properties of platelets in man. J Clin Invest. 1968 Sep;47(9):2169–2180. doi: 10.1172/JCI105903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Weiss H. J. Platelet aggregation, adhesion and adenosine diphosphate release in thrombopathia (platelet factor 3 deficiency). A comparison with Glanzmann's thrombasthenia and von Willebrand's disease. Am J Med. 1967 Oct;43(4):570–578. doi: 10.1016/0002-9343(67)90180-5. [DOI] [PubMed] [Google Scholar]
  41. Wolfe S. M., Shulman N. R. Adenyl cyclase activity in human platelets. Biochem Biophys Res Commun. 1969 Apr 29;35(2):265–272. doi: 10.1016/0006-291x(69)90277-0. [DOI] [PubMed] [Google Scholar]
  42. Zieve P. D., Greenough W. B., 3rd Adenyl cyclase in human platelets: activity and responsiveness. Biochem Biophys Res Commun. 1969 May 22;35(4):462–466. doi: 10.1016/0006-291x(69)90368-4. [DOI] [PubMed] [Google Scholar]
  43. Zucker M. B., Pert J. H., Hilgartner M. W. Platelet function in a patient with thrombasthenia. Blood. 1966 Oct;28(4):524–534. [PubMed] [Google Scholar]
  44. Zucker M. B., Peterson J. Inhibition of adenosine diphosphate-induced secondary aggregation and other platelet functions by acetylsalicylic acid ingestion. Proc Soc Exp Biol Med. 1968 Feb;127(2):547–551. doi: 10.3181/00379727-127-32737. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES